{
    "root": "f18c8af9-7dbb-44c2-b1eb-9d0d908f9c9b",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "esmolol hydrochloride",
    "value": "20230712",
    "ingredients": [
        {
            "name": "esmolol hydrochloride",
            "code": "V05260LC8D",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_4857"
        },
        {
            "name": "sodium acetate",
            "code": "4550K0SC9B",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32954"
        },
        {
            "name": "acetic acid",
            "code": "Q40Q9N063P",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15366"
        },
        {
            "name": "sodium chloride",
            "code": "451W47IQ8X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_26710"
        },
        {
            "name": "hydrochloric acid",
            "code": "QTT17582CB",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37527"
        },
        {
            "name": "sodium hydroxide",
            "code": "55X04QC32I",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32145"
        },
        {
            "name": "water",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        }
    ],
    "indications": {
        "text": "esmolol hydrochloride sodium chloride injection beta adrenergic blocker indicated short-term treatment : control ventricular rate supraventricular tachycardia including atrial fibrillation atrial flutter control heart rate noncompensatory sinus tachycardia ( 1.1 ) control perioperative tachycardia hypertension ( 1.2 )",
        "doid_entities": [
            {
                "text": "atrial fibrillation (DOID:0060224)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0060224"
            },
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "administer intravenously ( 2.1 , 2.2 ) titrate using ventricular rate blood pressure \u22654-minute intervals ( 2.1 , 2.2 ) supraventricular tachycardia ( svt ) noncompensatory sinus tachycardia ( 2.1 ) optional loading dose : 500 mcg per kg infused one minute 50 mcg per kg per minute next 4 minutes adjust dose needed maximum 200 mcg per kg per minute additional loading doses may administered perioperative tachycardia hypertension ( 2.2 ) loading dose : 500 mcg per kg 1 minute gradual control ( 1 mg per kg 30 seconds immediate control ) 50 mcg per kg per minute gradual control ( 150 mcg per kg per min immediate control ) adjusted maximum 200 ( tachycardia ) 300 ( hypertension ) mcg per kg per min ( 2.2 )",
        "doid_entities": [
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": null,
    "adverseReactions": "esmolol hydrochloride contraindicated patients : severe sinus bradycardia : may precipitate worsen bradycardia resulting cardiogenic shock cardiac arrest [ ( 5.2 ) ] . heart block greater first degree : second- third-degree atrioventricular block may precipitate worsen bradycardia resulting cardiogenic shock cardiac arrest [ ( 5.2 ) ] . sick sinus syndrome : may precipitate worsen bradycardia resulting cardiogenic shock cardiac arrest [ ( 5.2 ) ] . decompensated heart failure : may worsen heart failure . cardiogenic shock : may precipitate cardiovascular collapse cause cardiac arrest . iv cardiodepressant calcium-channel antagonists ( e.g . , verapamil ) esmolol hydrochloride close proximity ( i.e . , cardiac effects still present ) ; fatal cardiac arrests occurred patients receiving esmolol hydrochloride intravenous verapamil . pulmonary hypertension : may precipitate cardiorespiratory compromise . hypersensitivity , including anaphylaxis , esmolol inactive ingredients product ( cross-sensitivity beta blockers possible ) .",
    "indications_original": "Esmolol Hydrochloride in Sodium Chloride Injection is a beta adrenergic blocker indicated for the short-term treatment of: Control of ventricular rate in supraventricular tachycardia including atrial fibrillation and atrial flutter and control of heart rate in noncompensatory sinus tachycardia ( 1.1 ) Control of perioperative tachycardia and hypertension ( 1.2 )",
    "contraindications_original": "Administer intravenously ( 2.1 , 2.2 ) Titrate using ventricular rate or blood pressure at \u22654-minute intervals ( 2.1 , 2.2 ) Supraventricular tachycardia (SVT) or noncompensatory sinus tachycardia ( 2.1 ) Optional loading dose: 500 mcg per kg infused over one minute Then 50 mcg per kg per minute for the next 4 minutes Adjust dose as needed to a maximum of 200 mcg per kg per minute Additional loading doses may be administered Perioperative tachycardia and hypertension ( 2.2 ) Loading dose: 500 mcg per kg over 1 minute for gradual control (1 mg per kg over 30 seconds for immediate control) Then 50 mcg per kg per minute for gradual control (150 mcg per kg per min for immediate control) adjusted to a maximum of 200 (tachycardia) or 300 (hypertension) mcg per kg per min ( 2.2 )",
    "adverseReactions_original": "Esmolol hydrochloride is contraindicated in patients with:\n\n                  \n                     Severe sinus bradycardia: May precipitate or worsen bradycardia resulting in cardiogenic shock and cardiac arrest [see Warnings and Precautions (5.2)].\n                     \n                     Heart block greater than first degree: Second- or third-degree atrioventricular block may precipitate or worsen bradycardia resulting in cardiogenic shock and cardiac arrest [see Warnings and Precautions (5.2)].\n                     \n                     Sick sinus syndrome: May precipitate or worsen bradycardia resulting in cardiogenic shock and cardiac arrest [see Warnings and Precautions (5.2)].\n                     \n                     Decompensated heart failure: May worsen heart failure.\n\n                     Cardiogenic shock: May precipitate further cardiovascular collapse and cause cardiac arrest.\n\n                     IV administration of cardiodepressant calcium-channel antagonists (e.g., verapamil) and esmolol hydrochloride in close proximity (i.e., while cardiac effects from the other are still present); fatal cardiac arrests have occurred in patients receiving esmolol hydrochloride and intravenous verapamil.\n\n                     Pulmonary hypertension: May precipitate cardiorespiratory compromise.\n\n                     Hypersensitivity reactions, including anaphylaxis, to esmolol or any of the inactive ingredients of the product (cross-sensitivity between beta blockers is possible).",
    "drug": [
        {
            "name": "esmolol hydrochloride",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_4857"
        }
    ]
}